CVE-2023-47254

CRITICALCVSS 9.8/10EPSS 2.20%

Last modified

CVE-2023-47254 is a critical-severity vulnerability rated 9.8/10 on the CVSS scale. An OS Command Injection in the CLI interface on DrayTek Vigor167 version 5.2.2, allows remote attackers to execute arbitrary system commands and escalate privileges via any account created within the web interface.. EPSS estimates a 2.20% chance of exploitation in the next 30 days.

Description

An OS Command Injection in the CLI interface on DrayTek Vigor167 version 5.2.2, allows remote attackers to execute arbitrary system commands and escalate privileges via any account created within the web interface.

Metrics

CVSS 3.1
9.8/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
2.20%

80.3th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
DraytekVigor167 Firmware5.2.2

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2023-47254?
An OS Command Injection in the CLI interface on DrayTek Vigor167 version 5.2.2, allows remote attackers to execute arbitrary system commands and escalate privileges via any account created within the web interface.
How severe is CVE-2023-47254?
CVE-2023-47254 has a CVSS score of 9.8/10 (CRITICAL severity). The EPSS model estimates a 2.20% probability of exploitation in the next 30 days.
How do I fix CVE-2023-47254?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-47254?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST